Press Releases from Spaulding Clinical Research, LLC (5 total)
Spaulding Clinical Research Named “Best Phase I Drug Development CRO”
Spaulding Clinical Research, LLC, a global clinical pharmacology, cardiac safety and biometrics solutions provider, has been recognized as the Best Phase I Drug Development CRO in the 2016 International Life Sciences Awards. Spaulding Clinical Research was selected by an expert panel and based on customer reviews, capabilities, previous accolades and overall company performance.
The International Life Sciences Awards, sponsored by Global Health & Pharma (GHP) Magazine, “recognize the exceptional work of…
Spaulding Clinical to Disrupt Cardiac Safety Industry with Latest Innovation at …
Wireless, hand-held electrocardiograph designed to simplify the collection and transmission of ECG data for Pharmaceutical Sponsors
June 23, 2016 - West Bend, Wisconsin, USA - Spaulding Clinical Research, LLC, a global clinical pharmacology, cardiac safety and biometrics solutions provider, today announced that the Spaulding Electrocardiograph 2100iQ™ is to be exhibited at the Drug Information Association’s (DIA) 2016 conference.
The Spaulding 12-Lead ECG product line was originally launched in…
Spaulding Clinical Research Announces Addition to Cardiac Core Lab Management Te …
Shane Braninburg Joins Cardiac Safety Solutions Team to Support Growth Initiatives
June 07, 2016 - West Bend, Wisconsin, USA - Spaulding Clinical Research, LLC, a global clinical pharmacology, cardiac safety and biometrics solutions provider, today announced the addition of Shane Braninburg as Senior Director of Core Lab Services. Mr. Braninburg brings more than 15 years of global business expertise to Spaulding, including extensive operational and management experience…
Spaulding Clinical Receives FDA 510(k) Clearance for 12-Lead ECG Device
Wireless, hand-held electrocardiograph designed to streamline the collection and transmission of ECG data for doctors and patients.
May 24, 2016 - West Bend, Wisconsin, USA - Spaulding Medical, LLC, a wholly owned subsidiary of Spaulding Clinical Research, LLC and provider of cardiac safety solutions, today announced the FDA 510(k) Clearance for their newest 12-Lead ECG device: the Spaulding Electrocardiograph 2100iQ™.
The Spaulding 12-Lead ECG product line was originally launched in 2011 and…
Spaulding Clinical Research, A Full-Service CRO, To Present Company Metrics At A …
Spaulding Clinical Research, LLC, a full-service CRO announced today that they will be in attendance at the American Society for Clinical Pharmacology and Therapeutics’ (ASCPT) 2016 Annual Meeting. The event is scheduled to take place at the Hilton Bayfront in San Diego, California a from March 8th through the 12th. Spaulding Clinical Research will be exhibiting at Booth #54 and will be showcasing their industry leading Clinical Pharmacology and ECG…
